← Back
Data updated: Mar 10, 2026
ATNAHS PHARMA US
Immunology
ATNAHS PHARMA US is a major pharmaceutical company focused on Immunology.
1976
Since
5
Drugs
-
Trials
59
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
KETOROLAC TROMETHAMINE 2026-01-22
Labeling
KETOROLAC TROMETHAMINE 2024-11-21
Labeling
KETOROLAC TROMETHAMINE 2024-11-21
Labeling
KETOROLAC TROMETHAMINE 2024-11-21
Labeling
KETOROLAC TROMETHAMINE 2024-11-21
Labeling
KETOROLAC TROMETHAMINE 2024-11-21
Labeling
KETOROLAC TROMETHAMINE 2024-11-21
Labeling
KETOROLAC TROMETHAMINE 2024-11-21
Labeling
KETOROLAC TROMETHAMINE 2024-11-21
Labeling
KETOROLAC TROMETHAMINE 2024-11-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
3 drugs
Pipeline Strength Pro
Loading...
Active (4)
Discontinued (1)
Company Info
- First Approval
- 1976-03-11
- Latest
- 2024-11-21
- Applications
- 5